Boston Scientific plans two-for-one stock split
This article was originally published in Clinica
Executive Summary
Boston Scientific's share price has risen so sharply over the past two years that it has become too expensive for some investors. The company's board of directors has therefore approved a two-for-one stock split, "to provide a trading price range that is accessible to a broader group of investors", it said.